Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
نویسندگان: هلدا توتونچی , مجید مبصری , سمیرا پورمرادیان , حمید سلیمان زاده , بهنام کفیل قاضی جهانی , ندا اکبری , علیرضا استاد رحیمی
کلمات کلیدی: boron-containing compounds, COVID-19,oleoylethanolamide
نشریه: 33978 , 890 , 21 , 2020
| نویسنده ثبت کننده مقاله |
علیرضا استاد رحیمی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات علوم تغذیه |
| کد مقاله |
74857 |
| عنوان فارسی مقاله |
Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial |
| عنوان لاتین مقاله |
Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial |
| ناشر |
8 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Letter to Editor |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Objectives. In this study, we investigate the effect of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19.The current study is a single-center, randomized, double-blind, placebo-controlled clinical trial with parallel groups.The inclusion criteria include male and female patients≥18 years of age, with a confirmed diagnosis of SARS-CoV-2 infection via polymerase chain reaction (PCR) and/or antibody test and with written informed consent to participate in this trial. The exclusion criteria include regular use of any other supplement, severe and critical COVID-19 pneumonia, pregnancy and breastfeeding. This study is being conducted at Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Main text.pdf | 1399/10/23 | 424647 | دانلود |
